IRIS
STEFANINI, Giulio Giuseppe
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 5.181
EU - Europa 1.155
AS - Asia 365
AF - Africa 181
OC - Oceania 12
SA - Sud America 12
Continente sconosciuto - Info sul continente non disponibili 5
Totale 6.911
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 5.157
FI - Finlandia 363
IE - Irlanda 260
CN - Cina 231
NG - Nigeria 177
DE - Germania 106
SE - Svezia 102
FR - Francia 94
NL - Olanda 73
IN - India 62
IT - Italia 57
GB - Regno Unito 36
TR - Turchia 25
CA - Canada 20
BE - Belgio 18
RU - Federazione Russa 14
AU - Australia 8
IL - Israele 8
GR - Grecia 7
SG - Singapore 7
A2 - ???statistics.table.value.countryCode.A2??? 5
HK - Hong Kong 5
RO - Romania 5
TH - Thailandia 5
TW - Taiwan 5
ES - Italia 4
NZ - Nuova Zelanda 4
PE - Perù 4
UA - Ucraina 4
BR - Brasile 3
CL - Cile 3
CU - Cuba 3
JP - Giappone 3
PH - Filippine 3
AT - Austria 2
IR - Iran 2
MD - Moldavia 2
MY - Malesia 2
SA - Arabia Saudita 2
UG - Uganda 2
ZA - Sudafrica 2
AE - Emirati Arabi Uniti 1
AR - Argentina 1
CR - Costa Rica 1
DK - Danimarca 1
EC - Ecuador 1
ID - Indonesia 1
IM - Isola di Man 1
KW - Kuwait 1
KZ - Kazakistan 1
ME - Montenegro 1
NO - Norvegia 1
PL - Polonia 1
PT - Portogallo 1
RS - Serbia 1
SI - Slovenia 1
VN - Vietnam 1
Totale 6.911
Salva come PNG Salva come JPEG
Città #
Chandler 988
Wilmington 959
San Mateo 418
Helsinki 363
Dublin 259
Ann Arbor 231
Shanghai 225
Boardman 212
Ashburn 195
Lawrence 182
Princeton 182
Benin City 177
New York 177
Leawood 148
Woodbridge 99
Fairfield 91
Paris 89
Amsterdam 72
Pune 55
Los Angeles 33
Kocaeli 24
London 24
Seattle 22
Milan 21
Norwalk 20
San Diego 20
Brussels 18
Falkenstein 14
Toronto 14
Redmond 13
Phoenix 11
Abbiategrasso 10
Redwood City 10
Des Moines 8
Moscow 6
Cambridge 5
Bangkok 4
Clearwater 4
Houston 4
Lima 4
Long Beach 4
Taipei 4
Augsburg 3
Badia Polesine 3
Gunzenhausen 3
Havana 3
Kemerovo 3
Monmouth Junction 3
Stockholm 3
Sydney 3
São Paulo 3
Athens 2
Carbonara al Ticino 2
Central 2
Chisinau 2
Cupertino 2
Delhi 2
Duncan 2
Guangzhou 2
Hangzhou 2
Kampala 2
Kuala Lumpur 2
Lübeck 2
Melbourne 2
Milwaukee 2
Mykolayiv 2
Turin 2
Vittoria 2
Alma 1
Almaty 1
Arvada 1
Auckland 1
Azilda 1
Baltimore 1
Belgrade 1
Bilgi 1
Brisbane 1
Caloocan City 1
Central District 1
Chennai 1
Chicago 1
Colchester 1
Douglas 1
Dundee 1
Durban 1
Esslingen am Neckar 1
Eugene 1
Ferrara 1
Frankfurt am Main 1
Gloucester 1
Granada 1
Grand Falls-Windsor 1
Groningen 1
Hackney 1
Hamilton 1
Hanoi 1
Harlingen 1
Henderson 1
Hunedoara 1
Hyderabad 1
Totale 5.512
Salva come PNG Salva come JPEG
Nome #
CAD in TAVI patients: relevance of disease complexity 62
Does clinical data quality affect fluid-structure interaction simulations of patient-specific stenotic aortic valve models? 62
On the Modeling of Patient-Specific Transcatheter Aortic Valve Replacement: A Fluid-Structure Interaction Approach 61
2014 ESC/EACTS Guidelines on myocardial revascularization 59
Monotherapy with a P2Y12 inhibitor or aspirin for secondary prevention in patients with established atherosclerosis: a systematic review and meta-analysis. 59
How should I treat a DES restenosis in a graft anastomosis with challenging access and multiple previous coronary interventions? 58
Additive effect of anemia and renal impairment on long-term outcome after percutaneous coronary intervention. 56
2014 ESC/EACTS Guidelines on myocardial revascularization. 56
Early detection of elevated cardiac biomarkers to optimise risk stratification in patients with COVID-19 56
Endovascular treatment vs. intravenous thrombolysis alone for ischaemic stroke: a meta-analysis of randomised controlled trials 55
Fractional Flow Reserve-Guided Multivessel Angioplasty in Myocardial Infarction. 55
2014 ESC/EACTS Guidelines on myocardial revascularization 55
Direct oral anticoagulants in addition to antiplatelet therapy for secondary prevention after acute coronary syndromes: an updated systematic review and meta-analysis 55
Continuation versus discontinuation of ACE inhibitors or angiotensin II receptor blockers in COVID-19: Effects on blood pressure control and mortality 55
What constitutes sufficient clinical evidence for stents? SpotLITE on the evaluation of novel coronary devices. 54
2018 ESC/EACTS Guidelines on myocardial revascularization. 54
Coral Reef Aorta: A Rare Occlusive Disease of the Aorta Complicating Decision Making for Severe Aortic Stenosis Treatment. 54
Another reason to endorse and spread guidelines 53
Efficacy and Safety of Calcium Channel Blocker/Diuretics Combination Therapy in Hypertensive Patients: A Meta-Analysis. 52
Impact of Diabetes on Clinical Outcomes After Polymer-Free Amphilimus- and Biolimus-Eluting Stent Implantation 52
4-Year Clinical Outcomes and Predictors of Repeat Revascularization in Patients Treated With New Generation Drug-Eluting Stents in the RESOLUTE All Comers Randomized Trial. 52
2018 ESC/EACTS Guidelines on myocardial revascularization. 52
Will LEADERS-FREE change my practice? A randomised double-blind comparison of the BioFreedom (TM) drug-coated stent vs. the Gazelle (TM) bare metal stent in patients at high bleeding risk using a short (1 month) course of dual antiplatelet therapy 52
Clinical outcomes of bioresorbable versus durable polymer-coated everolimus-eluting stents in real-world complex patients. 51
Meta-Analysis of Randomized Controlled Trials of Percutaneous Coronary Intervention With Drug-Eluting Stents Versus Coronary Artery Bypass Grafting in Left Main Coronary Artery Disease. 51
The association between in-stent neoatherosclerosis and native coronary artery disease progression: a long-term angiographic and optical coherence tomography cohort study 51
Safety and efficacy of drug-eluting stents in women: a patient-level pooled analysis of randomised trials. 51
Critical Organizational Issues for Cardiologists in the COVID-19 Outbreak: A Frontline Experience From Milan, Italy 51
Coronary stents: novel developments 50
Management of ST-elevation myocardial infarction according to European and American guidelines. 49
Impact of Diabetes Mellitus in Women Undergoing Percutaneous Coronary Intervention With Drug-Eluting Stents. 49
New approach to direct stenting using a novel 'All-In-One' coronary stent system via 5 french diagnostic catheters: A pilot study 49
Active surveillance for rheumatic heart disease in endemic regions: a systematic review and meta-analysis of prevalence among children and adolescents. 49
Is Transcatheter Aortic Valve Replacement Superior to Surgical Aortic Valve Replacement? A Meta-Analysis of Randomized Controlled Trials. 48
State of the art: coronary artery stents - past, present and future. 48
2018 ESC/EACTS Guidelines on myocardial revascularization 48
Surgical or percutaneous revascularization for isolated left anterior descending stenoses: are we in the same boat? 46
Myocardial revascularization appropriateness in Italy: measuring the unmeasured. 46
An update on drug-eluting stents versus bare-metal stents in PCI treatment: are there any remaining indications for BMS use? 46
Are the culprit lesions severely stenotic? 46
Clinical outcomes with reservoir-based polymer-free amphilimus-eluting stents in real-world patients according to diabetes mellitus and complexity: The INVESTIG8 registry. 46
ST-Elevation Myocardial Infarction in Patients with COVID-19: Clinical and Angiographic Outcomes 45
Aspiration Thrombectomy for Treatment of ST-segment Elevation Myocardial Infarction: a Meta-analysis of 26 Randomized Trials in 11 943 Patients 45
What's new in the 2018 ESC/EACTS guidelines on myocardial revascularization? 44
The synergy stent in high-bleeding risk patients: why design matters 44
Can Coronary Computed Tomography Angiography Replace Invasive Angiography? Coronary Computed Tomography Angiography Cannot Replace Invasive Angiography 44
Clinical outcome of patients with stable ischaemic heart disease as compared to those with acute coronary syndromes after percutaneous coronary intervention. 43
Coronary Revascularisation in Transcatheter Aortic Valve Implantation Candidates: Why, Who, When? Interv Cardiol. 43
Long-term outcomes of biodegradable polymer versus durable polymer drug-eluting stents in patients with diabetes a pooled analysis of individual patient data from 3 randomized trials. 43
Transcatheter aortic valve implantation using the ACURATE neo in bicuspid and tricuspid aortic valve stenosis: a propensity-matched analysis of a European experience. 43
Effects of Body Mass Index on Clinical Outcomes in Female Patients Undergoing Percutaneous Coronary Intervention With Drug-Eluting Stents: Results From a Patient-Level Pooled Analysis of Randomized Controlled Trials. 43
Long-Term Survival Following Multivessel Revascularization in Patients With Diabetes: The FREEDOM Follow-On Study. 43
Oral Anticoagulant Type and Outcomes After Transcatheter Aortic Valve Replacement. 43
A new device for vascular embolization: report on case of two pulmonary arteriovenous fistulas embolization using the amplatzer vascular plug 43
Safety and efficacy of polymer-free biolimus-eluting stents in all-comer patients: the RUDI-FREE study. 43
Predictors of Adverse Events Among Patient Undergoing Primary Percutaneous Coronary Intervention - Insights From a Pooled Analysis of the COMFORTABLE-AMI and EXAMINATION trials 43
Severe aortic stenosis and coronary artery disease. 43
Evolving Routine Standards in Invasive Hemodynamic Assessment of Coronary Stenosis: The Nationwide Italian SICI-GISE Cross-Sectional ERIS Study. 43
Adverse events while awaiting myocardial revascularization: a systematic review and meta-analysis. 43
The Contemporary Pulse of Bioresorbable-Scaffold Thrombosis Among Expert Operators 41
Safety and Efficacy of Resolute Zotarolimus-Eluting Stents Compared With Everolimus-Eluting Stents A Meta-Analysis 41
Higher in-hospital mortality during weekend admission for acute coronary syndrome: a large-scale cross-sectional Italian study 41
Transcatheter Self-Expandable Valve Implantation for Aortic Stenosis in Small Aortic Annuli: The TAVI-SMALL Registry. 41
Effect of Chronic Kidney Disease in Women Undergoing Percutaneous Coronary Intervention With Drug-Eluting Stents A Patient-Level Pooled Analysis of Randomized Controlled Trials 41
Duration of Dual Antiplatelet Therapy Following Drug-Eluting Stent Implantation in Diabetic and Non-Diabetic Patients: A Systematic Review and Meta-Analysis of Randomized Controlled Trials. 41
Safety and Efficacy of Polymer-Free Drug-Eluting Stents 41
Report of an ESC-EAPCI Task Force on the evaluation and use of bioresorbable scaffolds for percutaneous coronary intervention: executive summary. 41
Impact of sex on clinical and angiographic outcomes among patients undergoing revascularization with drug-eluting stents. 40
Validation of the Valve Academic Research Consortium Bleeding Definition in Patients With Severe Aortic Stenosis Undergoing Transcatheter Aortic Valve Implantation 40
Drug-Eluting Coronary Artery Stents 39
Role of Niacin in current clinical practice: A systematic review 39
Two-year clinical follow-up of the unrestricted use of the paclitaxel-eluting stent compared to the sirolimus-eluting stent as part of the Taxus-Stent Evaluated at Rotterdam Cardiology Hospital (T-SEARCH) registry 39
The impact of patient and lesion complexity on clinical and angiographic outcomes after revascularization with zotarolimus- and everolimus-eluting stents: a substudy of the RESOLUTE All Comers Trial 39
New-Generation Drug-Eluting Stents for Left Main In-Stent Restenosis: The DELTA-2 Registry. 39
Offline fusion of co-registered intravascular ultrasound and frequency domain optical coherence tomography images for the analysis of human atherosclerotic plaques. 39
Balloon Versus Self-Expandable Valve for the Treatment of Bicuspid Aortic Valve Stenosis: Insights from the BEAT International Collaborative Registrys 39
Biodegradable polymer drug-eluting stents reduce the risk of stent thrombosis at 4 years in patients undergoing percutaneous coronary intervention: a pooled analysis of individual patient data from the ISAR-TEST 3, ISAR-TEST 4, and LEADERS randomized trials 38
Safety of Prasugrel Loading Doses in Patients Pre-Loaded With Clopidogrel in the Setting of Primary Percutaneous Coronary Intervention Results of a Nonrandomized Observational Study 38
Effect of Increasing Stent Length on 3-Year Clinical Outcomes in Women Undergoing Percutaneous Coronary Intervention With New-Generation Drug-Eluting Stents: Patient-Level Pooled Analysis of Randomized Trials From the WIN-DES Initiative. 38
Long-term Safety and Efficacy of New-Generation Drug-Eluting Stents in Women With Acute Myocardial Infarction: From the Women in Innovation and Drug-Eluting Stents (WIN-DES) Collaboration. 38
Quantitative angiographic characterization of coronary artery disease in patients with human immunodeficiency virus (HIV) infection undergoing percutaneous coronary intervention. 38
The Valsalva maneuver in the diagnosis of patent foramen ovale. 37
Early Doppler-echocardiography evaluation of 597 prosthetic aortic valves. 37
The impact of anemia on long-term clinical outcome in patients undergoing revascularization with the unrestricted use of drug-eluting stents. 37
Clinical Outcomes and Revascularization Strategies in Patients With Low-Flow, Low-Gradient Severe Aortic Valve Stenosis According to the Assigned Treatment Modality 37
Correlates and Impact of Coronary Artery Calcifications in Women Undergoing Percutaneous Coronary Intervention With Drug-Eluting Stents: From the Women in Innovation and Drug-Eluting Stents (WIN-DES) Collaboration 37
Clinical Application of Biomarkers in Heart Failure with a Preserved Ejection Fraction: A Review 37
Report of an ESC-EAPCI Task Force on the evaluation and use of bioresorbable scaffolds for percutaneous coronary intervention: executive summary. 36
Long-term outcome of the unrestricted use of everolimus-eluting stents compared to sirolimus-eluting stents and paclitaxel-eluting stents in diabetic patients: the Bern-Rotterdam diabetes cohort study. 36
Coronary Artery Disease Severity and Aortic Stenosis: Clinical Outcomes According to SYNTAX-Score in Patients Undergoing Transcatheter Aortic Valve Implantation 36
Structure and functioning of the Heart Team: primum non nocere 36
Coronary artery disease in patients undergoing TAVI: why, what, when and how to treat. 36
Left atrial appendage closure with the Ultraseal device: Initial experience and mid-term follow-up. 36
Association of Hydroxychloroquine with QTc Interval in Patients with COVID-19 36
Acute coronary syndrome in a patient with a residual aortic dissection flap after supracoronary aortic replacement: the role of intravascular ultrasound 36
Development and validation of a risk score using complete blood count to predict in-hospital mortality in COVID-19 patients 36
Safety profile of prasugrel and clopidogrel in patients with acute coronary syndromes in Switzerland 35
Long-term clinical outcomes of biodegradable polymer biolimus-eluting stents versus durable polymer sirolimus-eluting stents in patients with coronary artery disease (LEADERS): 4 year follow-up of a randomised non-inferiority trial 35
Impact of stent overlap on long-term clinical outcomes in patients treated with newer-generation drug-eluting stents. 35
Independent impact of extent of coronary artery disease and percutaneous revascularization on 30-day and 1-year mortality after TAVI: a meta-analysis of adjusted observational results. 35
Totale 4.492
Salva come PNG Salva come JPEG
Categoria #
all - tutte 54.662
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 54.662
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20204 0 0 0 0 0 0 0 0 0 0 0 4
2020/20211.822 4 12 3 4 13 498 340 135 383 242 2 186
2021/2022905 24 10 16 246 6 2 21 149 73 68 246 44
2022/20232.901 423 110 237 316 316 209 13 217 520 288 192 60
2023/20241.566 213 147 393 116 98 264 143 126 21 45 0 0
Totale 7.198